Kovachich G B, Aronson C E, Brunswick D J
Department of Veterans Affairs Medical Center, University of Pennsylvania School of Medicine, Philadelphia.
Neuropsychopharmacology. 1992 Dec;7(4):317-24.
The binding of 3H-cyanoimipramine, a selective radioligand for the serotonin (5-HT) transporter, was measured by quantitative autoradiography on sections of rat brain to determine if 5-HT uptake sites are regulated by repeated administration of antidepressants. The drugs studied included selective inhibitors of the uptake of 5-HT (citalopram, sertraline) or norepinephrine (protriptyline). Also, effects of inhibitors of monoamine oxidase (MAO) that inhibit both type A and type B MAO (phenelzine), or just type B MAO (deprenyl), were investigated. In addition, the atypical antidepressant mianserin, which has antagonist properties at both alpha 2 adrenoceptors and 5-HT2 receptors, was studied. A total of 19 limbic areas and 4 regions of the parietal cortex were quantitated. The binding of 3H-cyanoimipramine was increased (14% to 31%) by phenelzine and deprenyl in a total of 3 brain areas and decreased (15% to 21%) by sertraline in 4 brain areas. Citalopram, protriptyline, and mianserin produced no statistically significant effect in any brain region examined. The results indicate that different types of antidepressants do not exert consistent or substantial regulatory effect on the density of uptake sites for 5-HT in the limbic system or parietal cortex.
通过对大鼠脑切片进行定量放射自显影,测定了3H-氰米帕明(一种用于血清素(5-HT)转运体的选择性放射性配体)的结合情况,以确定5-HT摄取位点是否受抗抑郁药重复给药的调节。所研究的药物包括5-HT摄取的选择性抑制剂(西酞普兰、舍曲林)或去甲肾上腺素摄取的选择性抑制剂(普罗替林)。此外,还研究了抑制A型和B型单胺氧化酶(MAO)的单胺氧化酶抑制剂(苯乙肼)或仅抑制B型MAO的抑制剂(司来吉兰)的作用。另外,还研究了非典型抗抑郁药米安色林,它对α2肾上腺素能受体和5-HT2受体均具有拮抗特性。总共对19个边缘区域和顶叶皮质的4个区域进行了定量分析。苯乙肼和司来吉兰在总共3个脑区使3H-氰米帕明的结合增加(14%至31%),而舍曲林在4个脑区使其结合减少(15%至21%)。西酞普兰、普罗替林和米安色林在任何检测的脑区均未产生统计学上显著的影响。结果表明,不同类型的抗抑郁药对边缘系统或顶叶皮质中5-HT摄取位点的密度没有一致或实质性的调节作用。